Awareness, treatment, control of hypertension, and associated factors: Results from a Turkish national study

Daştan, İlker; Erem, Aysegul; Cetinkaya, Volkan

doi:10.1080/10641963.2017.1334797

Cited by 29 publications

(23 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The difference in raised blood pressure in men and women (23.09% vs. 14.86%) in Vietnam found in this study was consistent with the findings from previous Vietnamese studies [5, 7, 8, 21]. This pattern was also comparable to other studies carried out in both developed and developing countries [3, 12, 14–18, 22]. In contrast to other studies, a meta-analysis of 45 countries found that there was no significant sex-difference in raised blood pressure prevalence [19].…”

Section: Discussionsupporting

confidence: 93%

“…The prevalence of raised blood pressure in the present study is lower than the prevalence of raised blood pressure in selected countries and regions such as Africa (30.8% in 2010) [11], China (from 20.5% to 28.7%) [12–16], Labanon (29.3%) [17], and Turkey (24.8%) [18]. Compared with the results from the systematic review and meta-analysis in 2015 comprising data on 45 low- and middle-income countries, which reported the pooled raised blood pressure prevalence of 37.8% (95% CI: 35.0–40.6) in upper middle-income countries and 23.1% (95% CI: 20.1–26.2) in low-income countries, the prevalence in Vietnam is also much lower [19].…”

Section: Discussioncontrasting

confidence: 53%

See 1 more Smart Citation

Patterns of Raised Blood Pressure in Vietnam: Findings from the WHO STEPS Survey 2015

Hoang

Tran

et al. 2019

International Journal of Hypertension

View full text Add to dashboard Cite

This study aims to describe the prevalence of raised blood pressure and the situation of management for raised blood pressure among the adult population in Vietnam. It also aims to examine the association between diversified socioeconomic and behavioral factors of raised blood pressure and awareness of raised blood pressure. Data were obtained from the STEPS survey conducted in Vietnam in 2015. Survey sample was nationally representative with a total of 3,856 people aged 18–69 years old. The study outcomes included raised blood pressure and awareness of and control of raised blood pressure. Multiple logistic regression was used to examine the association of socioeconomic and behavior risk factors with the outcome variables. The overall prevalence of raised blood pressure in Vietnam in 2015 was 18.9% (95% CI: 17.4%–20.6%). The prevalence of raised blood pressure was higher among men. Significantly correlated factors with raised blood pressure were age, sex, body mass index, and diabetes status. Levels of awareness of raised blood pressure were higher among the older age group and overweight people and lower among ethnic minority groups. Raised blood pressure in Vietnam is a serious problem due to its magnitude and the unacceptably high unawareness rate in the population. Public health actions dealing with the problems of raised blood pressure are urgent, while taking into account its relationship with sex and socioeconomic status. It is clear that the interventions should address all people in society, with a focus on disadvantaged groups which are the rural and ethnic minority peoples.

show abstract

Section: Discussionsupporting

confidence: 93%

Section: Discussioncontrasting

confidence: 53%

Patterns of Raised Blood Pressure in Vietnam: Findings from the WHO STEPS Survey 2015

Hoang

Tran

et al. 2019

International Journal of Hypertension

View full text Add to dashboard Cite

show abstract

“…We foundoverweight and obese patients had higherhypertension prevalenceand hypertension and T2DM treatment, but a lowerhypertension control rate. This was in agreement with other studies [25,42].Overweight and obesity increase hypertension and T2DM risks. There is research reporting that obese patients have received medications to lower their lipid, BPs, and plasma glucose levels, but this was correlatedinversely to how well their BP was controlled [43,44].…”

Section: Discussionsupporting

confidence: 94%

Time Trends in Comorbidity and Management of Hypertension and Diabetes: A 15-year Nationwide Longitudinal Study of 18,380 Adults in China

Sun

Wei

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: To examine time trends in comorbidity of hypertension and type 2 diabetes (T2DM) and their diagnosis, treatment, and management in China during 2000-2015 and study factors associated with these outcomes. Methods: Longitudinal data collected from the China Health and Nutrition Survey (CHNS) during 2000-2015 were analyzed. Of the 28,204 adults, 832 had both hypertension and T2DM were selected. Average systolic blood pressure (SBP) and diastolic blood pressure (DBP) and hypertension prevalence among T2DM patients, and treatment and control of hypertension and T2DM among patients with both conditions were examined for all and by sex and weight status. Mixed effects models assessed the associations. Results: From 2000 to 2015, among patients with T2DM, hypertension prevalence dropped from 88.4% to 83.0% and BPs decreased (P < 0.05). Men and overweight/obese patients had greater decreases in hypertension prevalence and DBP, while women had a larger decrease in SBP than men. Over time, among patients with both hypertension and T2DM, rates of hypertension treatment (45.3% to 57.7%), hypertension control (3.0% to 10.9%) and T2DM treatment (90.0% to 95.6%) increased, but were still very low except for T2DM treatment (all P < 0.001). Age, gender, smoking, drinking, household income, education, residence, and weight status were significantly associated with prevalence, treatment, and control of hypertension, and T2DM treatment among patients with both hypertension and T2DM. Conclusion: Rates of hypertension treatment and control among patients with both hypertension and T2DM have improved in recent years, but were still low.

show abstract

“…The prevalence and awareness of hypertension in Iran (compared based on the cut-off of 140/90 mmHg) resemble findings reported in other middle-income countries [26,27]. Despite a higher treatment rate in Iran, the control rate stood at 39.1%, which is yet noticeably lower than Turkey, with 53.9% in 2012, and Lebanon, with 54% in 2014 [28].…”

Section: Discussionsupporting

confidence: 68%

Insight into blood pressure targets for universal coverage of hypertension services in Iran: the 2017 ACC/AHA versus JNC 8 hypertension guidelines

et al. 2020

View full text Add to dashboard Cite

Background: We compared the prevalence, awareness, treatment, and control of hypertension in Iran based on two hypertension guidelines; the 2017 ACC/AHA-with an aggressive blood pressure target of 130/80 mmHg-and the commonly used JNC8 guideline cutoff of 140/90 mmHg. We shed light on the implications of the 2017 ACC/AHA for population subgroups and high-risk individuals who were eligible for non-pharmacologic and pharmacologic therapies. Methods: Data was obtained from the Iran national STEPS 2016 study. Participants included 27,738 adults aged ≥25 years as a representative sample of Iranians. Regression models of survey design were used to examine the determinants of prevalence, awareness, treatment, and control of hypertension. Results: The prevalence of hypertension based on JNC8 was 29.9% (95% CI: 29.2-30.6), which soared to 53.7% (52.9-54.4) based on the 2017 ACC/AHA. The percentage of awareness, treatment, and control were 59.2% (58.0-60.3), 80.2% (78.9-81.4), and 39.1% (37.4-40.7) based on JNC8, which dropped to 37.1% (36.2-38.0), 71.3% (69.9-72.7), and 19.6% (18.3-21.0), respectively, by applying the 2017 ACC/AHA. Based on the new guideline, adults aged 25-34 years had the largest increase in prevalence (from 7.3 to 30.7%). They also had the lowest awareness and treatment rate, contrary to the highest control rate (36.5%) between age groups. Compared with JNC8, based on the 2017 ACC/AHA, 24, 15, 17, and 11% more individuals with dyslipidaemia, high triglycerides, diabetes, and cardiovascular disease events, respectively, fell into the hypertensive category. Yet, based on the 2017 ACC/AHA, 68.2% of individuals falling into the hypertensive category were eligible for receiving pharmacologic therapy (versus 95.7% in JNC8). LDL cholesterol< 130 mg/dL, sufficient physical activity (Metabolic Equivalents≥600/week), and Body Mass Index were found to change blood pressure by − 3.56(− 4.38, − 2.74), − 2.04(− 2.58, − 1.50), and 0.48(0.42, 0.53) mmHg, respectively.

show abstract

Awareness, treatment, control of hypertension, and associated factors: Results from a Turkish national study

Abstract: This study recognized associated risk factors that may guide policies and interventions to enhance awareness, treatment, and control of HT in Turkey.

Cited by 29 publications

References 17 publications

Patterns of Raised Blood Pressure in Vietnam: Findings from the WHO STEPS Survey 2015

Patterns of Raised Blood Pressure in Vietnam: Findings from the WHO STEPS Survey 2015

Time Trends in Comorbidity and Management of Hypertension and Diabetes: A 15-year Nationwide Longitudinal Study of 18,380 Adults in China

Insight into blood pressure targets for universal coverage of hypertension services in Iran: the 2017 ACC/AHA versus JNC 8 hypertension guidelines

Contact Info

Product

Resources

About